Article info
Poster Presentations
Osteoarthritis
SAT0540 The reduction in adrenergic and inflammatory serum markers in osteoarthritis patients after treatment with chondroitin sulfate/glucosamine hydrochloride and celecoxib is different according to the presence of bacterial dna in blood
Citation
SAT0540 The reduction in adrenergic and inflammatory serum markers in osteoarthritis patients after treatment with chondroitin sulfate/glucosamine hydrochloride and celecoxib is different according to the presence of bacterial dna in blood
Publication history
- First published June 15, 2017.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions